• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

使用镓-喷替沙福PET/CT和氟代脱氧葡萄糖PET/CT对弥漫性大B细胞淋巴瘤反应的比较评估

Comparative Evaluation of Response in Diffuse Large B-cell Lymphoma Using Ga-Pentixafor PET/CT and F-FDG PET/CT.

作者信息

Palanivelu Pradap, Goyal Harish, Madivanane Vasanth, Ganesan Prasanth, Halanaik Dhanapathi, Kabilash D

机构信息

Department of Nuclear Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.

Department of Medical Oncology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.

出版信息

Indian J Nucl Med. 2025 May-Jun;40(3):152-155. doi: 10.4103/ijnm.ijnm_158_24. Epub 2025 Aug 7.

DOI:10.4103/ijnm.ijnm_158_24
PMID:40927157
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12416602/
Abstract

Diffuse large B-cell lymphoma (DLBCL) is a highly aggressive type of non-Hodgkin lymphoma. Accurate evaluation of treatment response is essential for effective management. This case report discusses the potential role of ⁶⁸Ga-Pentixafor positron emission tomography (PET)/computed tomography (CT) in comparison to F-fluorodeoxyglucose PET/CT for assessing treatment response in a patient with DLBCL.

摘要

弥漫性大B细胞淋巴瘤（DLBCL）是一种侵袭性很强的非霍奇金淋巴瘤。准确评估治疗反应对于有效管理至关重要。本病例报告讨论了⁶⁸Ga-喷替沙氟正电子发射断层扫描（PET）/计算机断层扫描（CT）与F-氟脱氧葡萄糖PET/CT相比，在评估一名DLBCL患者治疗反应中的潜在作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dd9/12416602/f1291aca814e/IJNM-40-152-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dd9/12416602/e0349d5e87ad/IJNM-40-152-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dd9/12416602/f1291aca814e/IJNM-40-152-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dd9/12416602/e0349d5e87ad/IJNM-40-152-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dd9/12416602/f1291aca814e/IJNM-40-152-g002.jpg

相似文献

1
Comparative Evaluation of Response in Diffuse Large B-cell Lymphoma Using Ga-Pentixafor PET/CT and F-FDG PET/CT.使用镓-喷替沙福PET/CT和氟代脱氧葡萄糖PET/CT对弥漫性大B细胞淋巴瘤反应的比较评估
Indian J Nucl Med. 2025 May-Jun;40(3):152-155. doi: 10.4103/ijnm.ijnm_158_24. Epub 2025 Aug 7.
2
Ga-pentixafor for PET imaging of chemokine receptor 4 expression in lymphoproliferative diseases and solid tumors.镓标记的喷替沙氟用于正电子发射断层显像（PET）检测淋巴增殖性疾病和实体瘤中趋化因子受体4的表达
Hell J Nucl Med. 2025 May-Aug;28(2):124-130. doi: 10.1967/s002449912803. Epub 2025 Aug 4.
3
Head-to-Head Comparison of Ga-PentixaFor PET/CT and FDG PET/CT for Detecting Hematologic and Solid Cancers: A Systematic Review and Meta-Analysis.镓标记的五肽胃泌素PET/CT与氟代脱氧葡萄糖PET/CT用于检测血液系统和实体瘤的头对头比较：一项系统评价和荟萃分析
AJR Am J Roentgenol. 2025 Aug;225(2):e2532708. doi: 10.2214/AJR.25.32708. Epub 2025 May 14.
4
Ga-68 Pentixafor PET/CT in multiple myeloma and its correlation with clinical parameters: institutional pilot study.镓-68喷替沙福PET/CT在多发性骨髓瘤中的应用及其与临床参数的相关性：机构性初步研究
Ann Nucl Med. 2025 Mar 7. doi: 10.1007/s12149-025-02036-5.
5
Diagnostic value of [ 68 Ga]Ga-Pentixafor PET/CT in malignant melanoma: a pilot study.[68Ga]Ga-戊基替昔福 PET/CT 在恶性黑色素瘤中的诊断价值：一项初步研究。
Nucl Med Commun. 2024 Mar 1;45(3):221-228. doi: 10.1097/MNM.0000000000001806. Epub 2024 Jan 12.
6
Association analysis of intratumoral metabolic heterogeneity assessed by the hottest lesion based on F-FDG PET/CT with immunochemotherapy response in diffuse large B-cell lymphoma.基于F-FDG PET/CT的最热病灶评估的肿瘤内代谢异质性与弥漫性大B细胞淋巴瘤免疫化疗反应的关联分析。
Quant Imaging Med Surg. 2025 Sep 1;15(9):8096-8111. doi: 10.21037/qims-2024-2699. Epub 2025 Aug 19.
7
Diagnostic Efficacy of F-FDG PET/CT in Detecting Bone Marrow Infiltration in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma.F-FDG PET/CT 在诊断初诊弥漫性大 B 细胞淋巴瘤患者骨髓浸润中的诊断效能。
Biomed Environ Sci. 2023 Jun 20;36(6):510-516. doi: 10.3967/bes2023.062.
8
Evaluating the diagnostic utility of [⁶⁸Ga]Ga-Pentixafor in solid tumors: a systematic review.评估[⁶⁸Ga]镓-喷替酸五乙酸在实体瘤中的诊断效用：一项系统评价。
Ann Nucl Med. 2025 Aug 15. doi: 10.1007/s12149-025-02093-w.
9
F-FDG parameters as therapy response predictors in patients with diffuse large B-cell lymphoma: A single centre experience.18F-氟脱氧葡萄糖参数作为弥漫性大B细胞淋巴瘤患者治疗反应预测指标：单中心经验
Hell J Nucl Med. 2025 May-Aug;28(2):115-123. doi: 10.1967/s002449912802. Epub 2025 Aug 4.
10
Total or partial adrenalectomy for aldosterone-producing adenoma: can Ga-Pentixafor PET/CT predict surgical outcomes?醛固酮瘤的全肾上腺切除术或部分肾上腺切除术：镓-喷替沙福PET/CT能否预测手术结果？
Eur J Nucl Med Mol Imaging. 2025 Apr 4. doi: 10.1007/s00259-025-07244-9.

本文引用的文献

1
Synthesis, Screening, and Evaluation of Theranostic Molecular CPCR4-Based Probe Targeting CXCR4.基于 CXCR4 的治疗分子 CPCR4 探针的合成、筛选和评价。
Mol Pharm. 2024 May 6;21(5):2415-2424. doi: 10.1021/acs.molpharmaceut.3c01221. Epub 2024 Apr 12.
2
Current Status of Ga-Pentixafor in Solid Tumours.镓-喷替沙氟在实体瘤中的研究现状
Diagnostics (Basel). 2022 Sep 2;12(9):2135. doi: 10.3390/diagnostics12092135.
3
CXCR4-Directed PET/CT with [Ga]Pentixafor in Central Nervous System Lymphoma: A Comparison with [F]FDG PET/CT.
[Ga]Pentixafor 引导的 CXCR4-PET/CT 与 [F]FDG PET/CT 在中枢神经系统淋巴瘤中的比较。
Mol Imaging Biol. 2022 Jun;24(3):416-424. doi: 10.1007/s11307-021-01664-3. Epub 2021 Oct 14.
4
CXCR4 PET imaging of mantle cell lymphoma using [Ga]Pentixafor: comparison with [F]FDG-PET.采用 [Ga]Pentixafor 进行套细胞淋巴瘤的 CXCR4 PET 成像：与 [F]FDG-PET 的比较。
Theranostics. 2021 Jan 1;11(2):567-578. doi: 10.7150/thno.48620. eCollection 2021.
5
Mechanisms and Implications of Metabolic Heterogeneity in Cancer.癌症代谢异质性的机制与意义。
Cell Metab. 2019 Sep 3;30(3):434-446. doi: 10.1016/j.cmet.2019.08.013.
6
C-X-C Chemokine Receptor 4 in Diffuse Large B Cell Lymphoma: Achievements and Challenges.C-X-C 趋化因子受体 4 在弥漫性大 B 细胞淋巴瘤中的作用：成就与挑战。
Acta Haematol. 2019;142(2):64-70. doi: 10.1159/000497430. Epub 2019 May 16.
7
Feasibility of CXCR4-Directed Radioligand Therapy in Advanced Diffuse Large B-Cell Lymphoma.CXCR4 导向放射性配体疗法治疗晚期弥漫性大 B 细胞淋巴瘤的可行性。
J Nucl Med. 2019 Jan;60(1):60-64. doi: 10.2967/jnumed.118.210997. Epub 2018 May 18.
8
Chemokine receptor - Directed imaging and therapy.趋化因子受体靶向成像与治疗。
Methods. 2017 Nov 1;130:63-71. doi: 10.1016/j.ymeth.2017.09.002. Epub 2017 Sep 12.
9
CXCR4 Ligands: The Next Big Hit?CXCR4配体：下一个热门靶点？
J Nucl Med. 2017 Sep;58(Suppl 2):77S-82S. doi: 10.2967/jnumed.116.186874.
10
First-in-Human Experience of CXCR4-Directed Endoradiotherapy with 177Lu- and 90Y-Labeled Pentixather in Advanced-Stage Multiple Myeloma with Extensive Intra- and Extramedullary Disease.177Lu和90Y标记的喷替沙肽靶向内照射治疗晚期多发性骨髓瘤伴广泛髓内和髓外病变的首例人体经验。
J Nucl Med. 2016 Feb;57(2):248-51. doi: 10.2967/jnumed.115.167361. Epub 2015 Nov 12.